This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.

Robert Broadnax

Vice President

Robert Broadnax has more than 25 years of pharma/biotech commercialization/marketing, sales, and advanced analytics experience ranging from early pipeline/NPP, to launch and in-line brands in specialty disease areas.

Mr. Broadnax has developed global and regional brand and go to market strategies, led launches of several new products in specialty diseases, and has helped numerous clients worldwide identify, prioritize and execute market opportunities to achieve strategic, financial and operational objectives.

Prior to joining CRA, Mr. Broadnax spent the first 18 years of his career in roles on the client side of the pharma/biotech industry, including at Bristol-Myers Squibb, UCB Inc. and Roche Pharmaceuticals. He has also been a Partner at C1 Consulting and General Manager of Aptitude Health.

Related capabilities
Related capabilities

Selected engagements

  • 01
    Creating a consortium of experts to lead fundamental advancements in subcutaneous (SC) drug development and delivery
    Client issue A group of leading formulation scientists and device developers in pharma and biotech from 15+ organizations sought expertise and guidance in...
    View engagement
  • 02
    Development of a strategically aligned and integrated US and EU HCP segmentation
    A leading pharmaceutical company sought support from CRA’s Life Sciences consultants in developing strategically aligned and integrated US and EU HCP
    View engagement

Latest insights

Credentials

Get In Touch
Robert Broadnax
New York +1-404-431-1306 rbroadnax@crai.com